![]() Light Tight: The MultiImageTM Light Cabinet From Alpha Innotech |
![]() Cool Camera: the ChemiImagerTM 4000 From Alpha Innotech |
To eliminate over-or under-exposure with chemiluminescent ...
Light Tight: The MultiImageTM Light Cabinet From Alpha Innotech Alpha Innotech Corporation (San Leandro, Calif.) recently introduced a new chemiluminescence and fluorescence imaging system. The ChemiImager(TM) 4000 is designed to document, analyze, and archive gels, membranes, films, chemiluminescent samples, and plates in a matter of minutes. Cool Camera: the ChemiImagerTM 4000 From Alpha Innotech At the heart of the ChemiImager 4000 is a thermoelectrically cooled CCD (charge-coupled device)
![]() Light Tight: The MultiImageTM Light Cabinet From Alpha Innotech |
![]() Cool Camera: the ChemiImagerTM 4000 From Alpha Innotech |
To eliminate over-or under-exposure with chemiluminescent ...


These fluttering sensations are the brain’s reaction to certain emotions, which can be amplified or soothed by the gut’s own “bugs".
View this Issue
Olga Anczukow and Ryan Englander discuss how transcriptome splicing affects immune system function in lung cancer.


In our next roundtable webinar, learn how scientists leverage spatial biology to map tissues, uncover cellular interactions, and advance disease research.

Discover how scientists use the latest gene editing tools to advance health research.


Fujirebio's Lumipulse® G pTau217/β-Amyloid 1-42 Plasma Ratio test has the potential to shorten the Alzheimer's disease diagnostic journey and enable earlier intervention through its accessibility and high diagnostic performance.


Ten-year Agreement to Provide a Secure, AI-enabled Forensic Laboratory Information Management System Supporting DHS Forensic, Scientific, and Testing Services

deliver robust, reproducible solutions for sample preparation enabling a new era of end-to-end standardization in proteomics

Enables higher-throughput, cost effective single-cell sequencing

Enables ultra-low variant detection across a range of key MRD targets in AML, including very large FLT3-ITDs